期刊文献+

珍珠层成骨活性物质的研究进展

Research progress of osteogenic active substances in nacre
下载PDF
导出
摘要 骨质疏松症是骨代谢异常导致的骨量减少及骨微结构改变,骨脆性增加后继发骨折的一类全身性骨病,近年来已成为影响老年生活质量的主要因素之一。目前,其治疗药物在疗效及长期应用上存在问题,而珍珠层含有成骨活性物质,具有应用于骨质疏松症及其他骨病的潜力。该文就珍珠层活性成分的特点、提取方法及成骨作用研究进展进行综述。 Osteoporosis is a systemic bone disease characterized by low bone mass and micro-architectural change of bone tissue,leading to an increased bone fragility which can lead to secondary fractures.It has become one of the major factors affecting the quality of life in recent years,especially for the elderly.Currently,treatment drugs have problems with their efficacy and long-term use.Nacre contains osteogenic active substances,which has the potential to be used in osteoporosis and other bone diseases.The characteristics,extraction,and osteogenesis of active components in nacre are reviewed in this paper.
作者 刘琳 徐普 LIU Lin;XU Pu(Stomatology Center,Haikou Hospital Affiliated to Xiangya Medical College of Central South University,Haikou 570100,China)
出处 《中国骨质疏松杂志》 CAS CSCD 北大核心 2023年第7期1007-1011,共5页 Chinese Journal of Osteoporosis
基金 国家自然科学基金(82060194) 海南省重点研发计划项目(ZDYF2022SHFZ119)。
关键词 珍珠层 活性物质 成骨 nacre active substance osteogenesis
  • 相关文献

参考文献5

二级参考文献18

  • 1Xi WU,Xunhao XIONG,Liping XIE,Rongqing ZHANG.Pf-Rel, a Rel/Nuclear Factor-κB Homolog Identified from the Pearl Oyster, Pinctada fucata[J].Acta Biochimica et Biophysica Sinica,2007,39(7):533-539. 被引量:11
  • 2Canalis E.Wnt signalling in osteoporosis:mechanisms and novel therapeutic approaches. Nat Rev Endocrinol . 2013
  • 3Wang Bing,Liu Kang,Lin Hui-Yi,Bellam Naresh,Ling Shiyun,Lin Weei-Chin.14-3-3Tau regulates ubiquitin-independent proteasomal degradation of p21, a novel mechanism of p21 downregulation in breast cancer. Molecular and Cellular Probes . 2010
  • 4Mackie E J,Tucker R P.Tenascin in bone morphogenesis: expression by osteoblasts and cell type-specific expression of splice variants. Journal of Cell Science . 1992
  • 5Joseph S. Butler,David W. Murray,Conor J. Hurson,Julie O’Brien,Peter P. Doran,John M. O’Byrne.??The role of Dkk1 in bone mass regulation: Correlating serum Dkk1 expression with bone mineral density(J)J. Orthop. Res. . 2011 (3)
  • 6Gaur Tripti,Lengner Christopher J,Hovhannisyan Hayk,Bhat Ramesh A,Bodine Peter V N,Komm Barry S,Javed Amjad,van Wijnen Andre J,Stein Janet L,Stein Gary S,Lian Jane B.Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. Journal of Biological Chemistry . 2005
  • 7Lin Grace L,Hankenson Kurt D.Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation. Journal of cellular biochemistry . 2011
  • 8Niida Atsushi,Hiroko Takatoshi,Kasai Mana,Furukawa Yoichi,Nakamura Yusuke,Suzuki Yutaka,Sugano Sumio,Akiyama Tetsu.DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway. Oncegene . 2004
  • 9Stavros C. Manolagas.??Wnt signaling and osteoporosis(J)Maturitas . 2014
  • 10Nicholas Harvey,Elaine Dennison,Cyrus Cooper.??Osteoporosis: A Lifecourse Approach(J)J Bone Miner Res . 2014 (9)

共引文献605

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部